Medicare Enrolled
Dr. Jerry Bagel, MD
Dermatology · East Windsor, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bagel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bagel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bagel
Dr. Jerry Bagel is a dermatology specialist in East Windsor, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bagel performed 9,679 Medicare services across 816 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bagel received a total of $1,774,676 from 52 pharmaceutical and/or device companies across 2255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bagel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in NJ
$1,774,676 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,679
Medicare services
Top 8% in NJ for dermatology
816
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~484 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, tildrakizumab, 1 mg | 7,700 | $110 | $251 |
| UV therapy with tar or petroleum jelly A treatment using ultraviolet radiation combined with the application of tar or petroleum jelly to the skin. |
772 | $103 | $162 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
235 | $5 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $97 | $242 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $69 | $182 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $11 | $65 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $46 | $122 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
87 | $47 | $196 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
81 | $74 | $298 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
44 | $96 | $301 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
44 | $75 | $223 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $132 | $324 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
23 | $55 | $146 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
20 | $92 | $288 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
20 | $1 | $10 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
18 | $41 | $168 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
17 | $41 | $138 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
13 | $131 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,774,676
Total received (2018-2024)
Avg $253,525/year across 7 years
Top 0% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
2,255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,557,861 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$208,470 (11.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,345 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$150,410
2023
$225,384
2022
$319,786
2021
$241,038
2020
$121,420
2019
$260,989
2018
$455,651
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$56,100
ABBVIE INC.
$47,303
Incyte Corporation
$35,121
Lilly USA, LLC
$4,244
MAYNE PHARMA COMMERCIAL LLC
$3,480
LEO Pharma Inc.
$1,920
Janssen Biotech, Inc.
$661
Dermavant Sciences, Inc.
$368
Novartis Pharmaceuticals Corporation
$325
SUN PHARMACEUTICAL INDUSTRIES INC.
$267
PFIZER INC.
$187
Galderma Laboratories, L.P.
$124
Amgen Inc.
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Arcutis Biotherapeutics, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$18
Ortho Dermatologics, a division of Bausch Health US, LLC
$18
Sandoz Inc.
$18
GENZYME CORPORATION
$17
UCB, Inc.
$16
Janssen Scientific Affairs, LLC
$15
Top 3 companies account for 92.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$338,191
ABBVIE INC.
$160,327
AbbVie Inc.
$156,614
E.R. Squibb & Sons, L.L.C.
$149,344
AbbVie, Inc.
$144,560
Janssen Scientific Affairs, LLC
$133,421
Incyte Corporation
$122,963
Novartis Pharmaceuticals Corporation
$110,232
Ortho Dermatologics, a division of Bausch Health US, LLC
$74,070
Regeneron Healthcare Solutions, Inc.
$69,896
GENZYME CORPORATION
$62,553
Janssen Biotech, Inc.
$59,165
SUN PHARMACEUTICAL INDUSTRIES INC.
$29,437
Celgene Corporation
$21,933
UCB, Inc.
$21,312
LEO Pharma Inc.
$20,960
Eli Lilly and Company
$20,074
Dermavant Sciences, Inc.
$15,550
LEO Pharma AS
$12,330
Boehringer Ingelheim Pharmaceuticals, Inc.
$11,726
Sun Pharmaceutical Industries Inc.
$11,231
UCB SA
$8,220
Amgen Inc.
$7,793
Mindera Corp
$4,225
MAYNE PHARMA COMMERCIAL LLC
$3,480
UCB Biosciences Inc.
$2,645
Encore Dermatology Inc.
$614
PFIZER INC.
$468
Allergan, Inc.
$271
Galderma Laboratories, L.P.
$267
Mayne Pharma Inc.
$137
Arcutis Biotherapeutics, Inc.
$93
Kyowa Kirin, Inc.
$91
Amryt Pharma Holdings Ltd
$74
Teva Pharmaceuticals USA, Inc.
$58
EPI Health, LLC
$43
VYNE Pharmaceuticals Inc.
$42
Almirall LLC
$41
DERMIRA, INC.
$28
SANOFI-AVENTIS U.S. LLC
$20
Janssen Pharmaceuticals, Inc
$18
Sandoz Inc.
$18
ORGANOGENESIS INC.
$18
Blueprint Medicines Corporation
$16
MAYNE PHARMA INC.
$16
DUSA Pharmaceuticals, Inc.
$15
Promius Pharma LLC
$15
Taro Pharmaceuticals USA, Inc.
$14
Biofrontera Inc.
$14
Merck Sharp & Dohme Corporation
$13
TARO PHARMACEUTICALS USA, INC.
$12
PruGen, Inc. Pharmaceuticals
$12
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · ADBRY · AKLIEF · AMELUZ · AMJEVITA · AMZEEQ · ARAZLO · Absorica LD · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BRYHALI · Bimekizumab · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EUCRISA · Enbrel · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · HYRIMOZ · Halog · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · LIBTAYO · LUZU LULICONAZOLE · Mind.PX · OPZELURA · ORACEA · Otezla · PICATO · POTELIGEO · Puraply · REMICADE · RETIN-A MICRO · RETIN-A-MICRO · RINVOQ · Rinvoq · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Sernivo Spray · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · Truxima · USP) 0.1% · VTAMA · Veltin · Winlevi · XELJANZ · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for dermatology in NJ.
Geographic Context
Dermatologists within 10 mi
105
Per 100K population
27.4
County median income
$96,333
Nearest hospital
UNIVERSITY MEDICAL CENTER OF PRINCETON AT PLAINSBORO
5.9 mi
5.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bagel is a mixed practice specialist, with above-average Medicare volume (top 8% in NJ), with speaking/promotional industry engagement in the top 0% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bagel experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Bagel performed 7,700 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bagel receive payments from pharmaceutical companies?
Yes. Dr. Bagel received a total of $1,774,676 from 52 companies across 2,255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bagel's costs compare to other dermatologists in East Windsor?
Dr. Bagel's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bagel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in East Windsor
Browse dermatologists in East Windsor ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NJ
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NJ
Which NJ dermatologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology